Zephyr AI Stock

www.zephyrai.bioHealthcare / Other HealthcareFounded: 2020

Zephyr AI is a healthcare technology company that aims to develop new precision medicine treatments in oncology and cardiometabolic diseases. The company uses its platform’s AI capabilities and data analytics to look at vast amounts of healthcare information. With this, the company has a mission to serve patients through tailored treatment plans, potential new drug discoveries, repositioning existing drugs for new use cases, and clinical decision support that seeks to enable doctors to make informed decisions. Zephyr AI was founded by Grant L. Verstandig and Jeff Sherman in 2020 and is headquartered in Fairfax, VA.

Register To Buy and Sell Shares

For more details on financing and valuation for Zephyr AI, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Zephyr AI’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Zephyr AI.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Zephyr AI investors also invested in these private companies

Team

Management Team

Jeff Sherman
Co-Founder, Interim Chief Executive Officer & Chief Technology Officer
Rob Myers
Chief Operating Officer
George Komatsoulis Ph.D
Chief Data Officer
Yisroel Brumer Ph.D
Co-Founder
Grant Verstandig
Co-Founder

Board Members

Kenneth Samet
MedStar Health

Zephyr AI’s stock FAQs

plusminus

Can you buy Zephyr AI’s stock?

Zephyr AI is not publicly traded on NYSE or NASDAQ in the U.S. To buy Zephyr AI’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Zephyr AI’s stock?

Yes, you can sell stock of a private company like Zephyr AI. Forge can help you sell your Zephyr AI stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus

What is Zephyr AI’s stock price?

Zephyr AI is a privately held company and therefore does not have a public stock price. However, you may access Zephyr AI’s private market stock price with Forge Data.
plusminus

What is Zephyr AI’s stock ticker symbol?

Zephyr AI does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Zephyr AI Raises $111 Million in Series A Financing

Zephyr AI, a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) solutions to democratize precision medicine, today announced it has successfully closed a $111 million Series A funding round with participation from Revolution Growth, Eli Lilly & Company, Jeff Skoll, and EPIQ Capital Group, among others.
Updated on: Jul 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.